Annals of Surgical Oncology

, Volume 18, Issue 2, pp 380–385 | Cite as

Effectiveness of Image-Guided Radiotherapy for Locally Advanced Rectal Cancer

  • Nam P. Nguyen
  • Misty Ceizyk
  • Fabio Almeida
  • Alexander Chi
  • Michael Betz
  • Homayoun Modarresifar
  • Thomas Sroka
  • Deirdre Cohen
  • Siyoung Jang
  • Dave Abraham
  • Michelle Stevie
  • Lexie Smith-Raymond
  • Shane Krafft
  • Vincent Vinh-Hung
Gastrointestinal Oncology

Abstract

Background

Image-guided radiotherapy (IGRT) combines precise target visualization with optimal delivery of radiation dose to spare normal tissue from radiation and may potentially reduce side-effects and long-term treatment complications. We have assessed the effectiveness of IGRT for locally advanced rectal cancer.

Methods

A retrospective review of 22 patients with locally advanced rectal cancer who underwent preoperative chemoradiation was conducted.

Results

Nineteen patients (median age, 69 years) underwent surgical resection after chemoradiation. All 19 patients achieved complete resection with negative margins. Seven patients (32%) had no residual tumor in the surgical specimen. One patient had grade 4 gastrointestinal toxicity and hematological toxicity probably related to inadvertent overdosing of capecitabine. The median survival for the whole group—patients who had pCR and those who did not have pCR—was 14, 17, and 15 months, respectively.

Conclusions

Image-guided radiotherapy provided effective treatment for locally advanced rectal cancer with minimal toxicity and should be investigated in future prospective trials.

Keywords

Rectal Cancer Capecitabine Planning Target Volume Pelvic Lymph Node Gross Tumor Volume 

Notes

Conflict of interest

None.

References

  1. 1.
    Pilipshen SJ, Heilweil M, Quan SH, Sternberg SS, Enker W. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer. 1983;52:1317–29.CrossRefGoogle Scholar
  2. 2.
    Sauer R, Becker H, Hohenberger W, Rodel C, Witterkind C, Fietkau R, Martus P, Tschmelisch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.CrossRefPubMedGoogle Scholar
  3. 3.
    Nguyen NP, Sallah S, Karlsson U, Ludin A, Vos P, Lepera P, Jendrasiak G, Chapman W, Robiou C, Salehpour M. Combined preoperative chemotherapy and radiation for locally advanced cancer. Am J Clin Oncol. 2000;23:442–8.PubMedGoogle Scholar
  4. 4.
    Kalofonos HP, Bamias A, Koutras A, Papakosta P, Basdanis G, Samanta E, Karina M, Misailidou D, Pisanisis N, Pentheroudakis G, Economopoulos T, Papadimitriou C, Skarlos DV, Pectasides D, Stavropoulos M, Bafakoulos D, Kardamakis D, Karanikiotis C, Vourli G, Fountzilas G. A randomized phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group study. Eur J Cancer. 2008;44:1693–700.CrossRefPubMedGoogle Scholar
  5. 5.
    Arbea L, Ramos LI, Martinez-Monge R, Moreno M, Aristu J. Intensity-modulated radiation therapy vs 3D conformal radiotherapy in locally advanced rectal cancer: dosimetric comparison and clinical implications. Radiat Oncol. 2010;5:17.CrossRefPubMedGoogle Scholar
  6. 6.
    Ballonoff A, Kavanaugh B, McCarter M, Kane M, Pearlman N, Nash R, Shah RJ, Raben D, Schefter T. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial. Am J Clin Oncol. 2008;31:264–70.CrossRefPubMedGoogle Scholar
  7. 7.
    Ippolito E, mertens I, Haustermans K, Gambacorta MA, Pasini D, Valentini V. IGRT in rectal cancer. Acta Oncol. 2008;47:1317–24.CrossRefPubMedGoogle Scholar
  8. 8.
    Beavis AW. Is tomotherapy the future of IMRT? Br. J Radiol. 2004;77:285–95.CrossRefPubMedGoogle Scholar
  9. 9.
    Engels B, De Ridder M, Tornel K, Sermeus A, De Coninck P, Verellen D, Storme GA. Preoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowels. Int J Radiat Oncol Biol Phys. 2009;74:1476–80.CrossRefPubMedGoogle Scholar
  10. 10.
    Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, Coco C, Romano M, Mantello G, Palazzi S, Mattia FO, Friso ML, Genovesi D, Vidali C, Gambacorta MA, Buffoli A, Lupatelli M, Favretto MS, La Torre G. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 pCR patients. Int J Radiat Oncol Biol Phys. 2008;72:99–107.CrossRefPubMedGoogle Scholar
  11. 11.
    Rullier A, Laurent C, Capdepont M, Vendrely V, Bioulac-Sage P, Rullier E. Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma. Am J Surg Pathol. 2010;34:562–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Wiltshire KL, Ward IG, Swallow C, Oza AM, Cummings B, Pond GR, Catton P, Kim J, Ringash J, Wong CS, Wong R, Siu LL, Moore M, Brierley J. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int J Radiat Oncol Biol Phys. 2006;64:709–16.CrossRefPubMedGoogle Scholar
  13. 13.
    Roh MS, Colangelo LH, O’Connell MJ, Yothers G, Deutsch M, Allegra CJ, Kahlenberg MS, Baez-Diaz L, Ursiny CS, Petrelli NJ, Wolmark N. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NASBP R-03. J Clin Oncol. 2009;27:5124–30.CrossRefPubMedGoogle Scholar
  14. 14.
    Collette L, Bosset JF, den Dulk M, Nguyen F, Mineur L, Maingon P, Radosevic-Jelic L, Pierart M, Calais G. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organization for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol. 2007;25:4379–86.CrossRefPubMedGoogle Scholar
  15. 15.
    Mohiuddin M, Winter K, Mitchell E, Hannah N, Yuen A, Nichols C, Shane R, Hayostek C, Willett C. Randomized phase II study of neoadjuvant combined modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group trial 0012. J Clin Oncol. 2006;24:650–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Fernandez-Martos C, Pericay C, Aparicio J, Salud A, Safont M, Massuti B, Vera R, Escudero P, Maurel J, Marcuello E, Mengual JL, Saigi E, Estevan R, Mira M, Polo S, Hernandez A, Gallen M, Arias F, Serra J, Alonzo V. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance image-defined, locally advanced rectal cancer. Grupo Cancer de Recto 3 study. J Clin Oncol. 2010;28:859–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Gerard JP, Azria D, Gourgou-Bourgade S, Martel-Lafflay I, Hennequin C, Etienne PL, Vendrely V, Francois E, de La Roche G, Bouche O, Mirabel X, Denis B, Mineur L, Berdah JF, Mahe MA, Becouarn Y, Dupuis O, Lledo G, Montoto-Grillot C, Conroy T. Comparison of two neoadjuvant chemoradiotherapy Regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/045-Prodige 2. J Clin Oncol. 2010;28:1638–44.CrossRefPubMedGoogle Scholar
  18. 18.
    Brandengen M, Tveit KM, Berglund A, Birkemeyer E, Frykholm G, Pahlman L, Wiig JN, Bystrom P, Bujko K, Glimelius B. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol. 2008;26:3687–94.CrossRefGoogle Scholar
  19. 19.
    Valentini V, Coco C, Minsky BD, Gambacorta MA, Cosimelli M, Bellvita R, Morganti AG, La Torre G, Trodella L, Genovesi D, Portaluri M, Maurizi-Enrici R. Randomized, multicenter, phase IIB study of preoperative Chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:403–12.CrossRefPubMedGoogle Scholar
  20. 20.
    De La Torre A, Garcia-Berrocal MI, Arias F, Marino A, Valcarcel F, Megallon R, Regueiro CA, Romero J, Zapata I, De La Fuente C, Fernandez-Lizarbe E, Vergara G, Belinchon B, Veiras M, Moleron R, Millan I. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral Uracil and Tegafur and oral Leucovorin vs. intravenous 5-Fluorouracil and Leucovorin. Int J Radiat Oncol Biol Phys. 2008;70:102–10.CrossRefGoogle Scholar
  21. 21.
    Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, Seitz JF, Buecher B, Mackiewicz R, Ducreux M, Bedenne L. Preoperative radiotherapy with or without concurrent Fluorouracil and Leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006;24:4620–5.CrossRefPubMedGoogle Scholar
  22. 22.
    Nguyen NP, Antoine JE, Dutta S, Karlsson U, Sallah S. Current concepts in radiation enteritis and implications for future clinical trials. Cancer. 2002;95:1151–63.CrossRefPubMedGoogle Scholar
  23. 23.
    Letschert JG, Lebesque JV, de Boer RW, Hart AA, Bartelink H. Dose-volume correlation in radiation-related late small bowel complications. Radioth Oncol. 1990;18:307–20.CrossRefGoogle Scholar
  24. 24.
    Jhaveri PM, Teh BS, Paulino AC, Smiedala MJ, Fahy B, Grant W, McGary J, Butler EB. Helical tomotherapy significantly reduces dose to normal tissues when compared to 3D-CRT for locally advanced rectal cancer. Technol Cancer Res Treat. 2009;8:379–85.PubMedGoogle Scholar
  25. 25.
    De Ridder M, Tournel K, van Nieuwenhove Y, Engels B, Hoorens A, Everaert H, de Beek BO, Vinh-Hung V, de Greve J, Delvaux G, Verellen D, Storme GA. Phase II study of preoperative helical tomotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2008;70:728–34.CrossRefPubMedGoogle Scholar
  26. 26.
    Mirabell R, Taussky D, Rinaldi O, Lomax A, Canales S, Escude L, Nouet P, Ozsoy O, Rouzaud M. Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild-to-moderate late rectal toxicity. Int J Radiat Oncol Biol Phys. 2003;57:1280–4.CrossRefGoogle Scholar
  27. 27.
    Sheng K, Molloy JA, Read PW. Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: a comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy. Int J Radiat Oncol Biol Phys. 2006;65:917–23.CrossRefPubMedGoogle Scholar
  28. 28.
    Nguyen NP, Ceizyk M, Vinh-Hung V, Davis R, Desai A, Abraham D, Krafft SP, Jang S, Watchman CJ, Ewell L, Hamilton R, Smith-Raymond L. Effectiveness of image-guided radiotherapy for laryngeal sparing in head and neck cancer. Oral Oncol. 2010;46:283–6.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2010

Authors and Affiliations

  • Nam P. Nguyen
    • 1
  • Misty Ceizyk
    • 1
  • Fabio Almeida
    • 1
  • Alexander Chi
    • 1
  • Michael Betz
    • 3
  • Homayoun Modarresifar
    • 2
  • Thomas Sroka
    • 1
  • Deirdre Cohen
    • 1
  • Siyoung Jang
    • 1
  • Dave Abraham
    • 1
  • Michelle Stevie
    • 1
  • Lexie Smith-Raymond
    • 1
  • Shane Krafft
    • 1
  • Vincent Vinh-Hung
    • 3
  1. 1.Department of Radiation OncologyUniversity of ArizonaTucsonUSA
  2. 2.Department of Nuclear MedicineUniversity of ArizonaTucsonUSA
  3. 3.Department of Radiation OncologyUniversity Hospitals of GenevaGenevaSwitzerland

Personalised recommendations